Evidence map›Paper›PMID 34361001›Full record

ArticleInternational journal of molecular sciences2021

Overexpression of

Gink N Yang, Parinaz Ahangar, Xanthe L Strudwick, Zlatko Kopecki, Allison J Cowin

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gink N YangRegenerative Medicine, Future Industries Institute, University of South Australia, Adelaide, SA 5000, Australia.
Parinaz AhangarRegenerative Medicine, Future Industries Institute, University of South Australia, Adelaide, SA 5000, Australia.
Xanthe L StrudwickRegenerative Medicine, Future Industries Institute, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0002-8557-3857
Zlatko KopeckiRegenerative Medicine, Future Industries Institute, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0002-8072-4222
Allison J CowinRegenerative Medicine, Future Industries Institute, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0003-2885-2080
University of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidermal progenitor cells divide symmetrically and asymmetrically to form stratified epidermis and hair follicles during late embryonic development. Flightless I (Flii), an actin remodelling protein, is implicated in Wnt/β-cat and integrin signalling pathways that govern cell division. This study investigated the effect of altering Flii on the divisional orientation of epidermal progenitor cells (EpSCs) in the basal layer during late murine embryonic development and early adolescence. The effect of altering Flii expression on asymmetric vs. symmetric division was assessed in vitro in adult human primary keratinocytes and in vivo at late embryonic development stages (E16, E17 and E19) as well as adolescence (P21 day-old) in mice with altered Flii expression (Flii knockdown:

Indexed as

Cell DivisionAnimalsbeta CateninCells, CulturedKeratinocytesMiceMice, Inbred BALB CMicrofilament ProteinsMouse Embryonic Stem CellsSkinSOX9 Transcription FactorTrans-Activatorsbeta CateninFlII protein, mouseMicrofilament ProteinsSox9 protein, mouseSOX9 Transcription FactorTrans-Activatorscell divisionembryonicepidermisprogenitor cellsskin

Identifiers

PMID34361001
PMCPMC8348627
OpenAlexW3187794798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.